The AIDS Research Advisory Committee (ARAC), which consists of leading HIV scientists, advocates and community members, meets three times a year on the National Institutes of Health campus in Bethesda, Maryland. to advise NIAID on its HIV/AIDS research programs. ARAC provides broad scientific, programmatic, and budgetary advice; reviews the status of projects managed by the NIAID Division of Acquired Immunodeficiency Syndrome (DAIDS); helps identify critical gaps in research; and reviews/approves all concepts for new NIAID-directed HIV/AIDS research initiatives.
The AIDS Vaccine Research Subcommittee (AVRS), formerly known as the AIDS Vaccine Research Working Group (AVRWG), assists NIAID in developing a comprehensive research program aimed at expediting the discovery and development of an effective HIV/AIDS vaccine. The subcommittee is composed of researchers and advocates engaged in HIV vaccine research.
The Strategic Working Group (SWG) provides expert advice on the scientific priorities of the NIAID-funded HIV/AIDS Clinical Trials Networks. Specifically, the SWG serves as a forum for discussion, resolution, and proactive planning of critical issues; provides guidance on scientific priorities for future high resource trials, provides input about budget allocation for future funding of the networks and sites, and facilitates communication among all stakeholders relevant to the NIAID-sponsored HIV/AIDS Clinical Trials Networks. The SWG meets two to three times a year, and members include the network principal investigators, NIAID-appointed external advisors, representatives from the Community Partners, and the director of DAIDS.
Last Updated November 24, 2009